Response varies by genetics, baseline skin tone, sun exposure, and consistency of use
4 More recently, the FDA Reauthorization Act of 2017 (FDARA) made a reference encouraging the enrollment of more diverse patient populations, and the Final Rule for Clinical Trials Registration and Results Information Submission (42 CFR Part 11) went into effect in January 2017
Melanotan I is still treated as a research chemical and we thus cannot draw conclusions about its safety
Research cycles typically run for 4 to 8 weeks, often followed by a break of 2 to 4 weeks before potentially resuming
J Inherit.Metab Dis 9-10-2010
For example, improved fasting glucose, reduced HbA1c, and better lipid profiles may indicate therapeutic success